mktcap_usd=201779
ConsensRecom=1.93
earning_yield=2.36%
growth=10.95%
dilution=3.48%
div_ratio=1.56
sh_payout_ratio=0
margin=9.07%
cfmargin=7.03%
ratiopaid=22.72%
sratiopaid=6.44%
ratioConsens=1.15
Description
AstraZeneca PLC is a science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Its pipeline forms a robust portfolio of investigational therapies in various stages of clinical development. Its pipeline includes the Alexion Rare Disease portfolio and comprises approximately 179 projects. Its key marketed oncology products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Zoladex, Faslodex and others. Its rare diseases products include Soliris, Ultomiris, Strensiq and Kanuma. Its BioPharmaceuticals products include Farxiga, Lokelma, Crestor, Breztri and others. Its geographical segments include United Kingdom, Rest of Europe, The Americas and Asia, Africa & Australasia. It is also focused on discovering, developing, and manufacturing of T-cell receptor therapies.
Income and Cashflow Statements USD
| EndDate | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | mean | std |
|---|---|---|---|---|---|---|---|---|---|
| sourceDate | 2017-03-07 | 2018-03-06 | 2019-03-05 | 2020-03-03 | 2021-02-15 | 2022-02-22 | 2023-02-21 | NaN | NaN |
| period | 12M | 12M | 12M | 12M | 12M | 12M | 12M | NaN | NaN |
| rev | 23002 | 22465 | 22090 | 24384 | 26617 | 37417 | 44351 | 28618 | 8745 |
| revgrowth | NaN | -2.36% | -1.68% | 9.88% | 8.76% | 34.06% | 17.00% | 10.94% | 13.52% |
| earn | 3499 | 3001 | 2155 | 1335 | 3196 | 112 | 3288 | 2369 | 1253 |
| earnx | 3499 | 2385 | 2155 | 1335 | 3196 | 112 | 3288 | 2281 | 1222 |
| margin | 15.21% | 13.36% | 9.76% | 5.47% | 12.01% | 0.30% | 7.41% | 9.07% | 5.13% |
| xmargin | 15.21% | 10.62% | 9.76% | 5.47% | 12.01% | 0.30% | 7.41% | 8.68% | 4.84% |
| earningyld | 6.30% | 4.79% | 2.87% | 1.38% | 3.24% | 0.09% | 1.90% | 2.94% | 2.10% |
| cfop | 4145 | 3578 | 2618 | 2969 | 4799 | 5963 | 9808 | 4840 | 2465 |
| cfinv | -3969 | -2328 | 963 | -657 | -285 | -11058 | -2960 | -2899 | 3975 |
| cffin | -1324 | -2936 | -2044 | -1765 | -2203 | 3649 | -6823 | -1921 | 3070 |
| cfopmargin | 18.02% | 15.93% | 11.85% | 12.18% | 18.03% | 15.94% | 22.11% | 16.29% | 3.58% |
| cfinvmargin | -17.26% | -10.36% | 4.36% | -2.69% | -1.07% | -29.55% | -6.67% | -9.04% | 11.39% |
| cffinmargin | -5.76% | -13.07% | -9.25% | -7.24% | -8.28% | 9.75% | -15.38% | -7.03% | 8.12% |
| shares | 12.5 | 12.5 | 12.5 | 12.9 | 13.0 | 14.1 | 15.4 | 13.3 | 1.10 |
| fx | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0 |
| price | 4438 | 5003 | 6006 | 7540 | 7598 | 8490 | 11218 | 7185 | 2308 |
| dilution | NaN | 0.08% | 0 | 2.65% | 0.92% | 8.33% | 8.91% | 3.48% | 4.10% |
| dividend | 3561 | 3519 | 3484 | 3592 | 3572 | 3856 | 4364 | 3707 | 314 |
| sharebb | NaN | -46.6 | 0 | -2275 | -897 | -9060 | -12948 | -4204 | 5471 |
| ltdebtbb | NaN | -1059 | -1799 | 1142 | -1777 | -10894 | 5198 | -1532 | 5300 |
| mgtbb | NaN | -523 | -359 | 694 | -1305 | -12449 | -10209 | -4025 | 5737 |
| divyld | 6.42% | 5.62% | 4.63% | 3.71% | 3.62% | 3.22% | 2.52% | 4.25% | 1.38% |
| sharebbyld | NaN | -0.08% | 0 | -2.65% | -0.92% | -8.33% | -8.91% | -3.48% | 4.10% |
| mgtyld | NaN | -0.83% | -0.48% | 0.72% | -1.32% | -10.40% | -5.90% | -3.04% | 4.26% |
Balance Sheet
| EndDate | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | mean | std |
|---|---|---|---|---|---|---|---|---|---|
| sourceDate | 2017-03-07 | 2018-03-06 | 2019-03-05 | 2020-03-03 | 2021-02-15 | 2022-02-22 | 2023-02-21 | NaN | NaN |
| mktcap | 55501 | 62627 | 75172 | 96912 | 98558 | 119691 | 172890 | 97336 | 40116 |
| mktcapgrowth | NaN | 12.08% | 18.26% | 25.40% | 1.68% | 19.43% | 36.77% | 18.94% | 11.88% |
| totAsset | 62526 | 63354 | 60651 | 61377 | 66729 | 105363 | 96483 | 73783 | 18816 |
| assetgrowth | NaN | 1.32% | -4.36% | 1.19% | 8.36% | 45.68% | -8.80% | 7.23% | 19.71% |
| curAsset | 13262 | 13150 | 15591 | 15563 | 19544 | 26244 | 22593 | 17992 | 4986 |
| curAssetPct | 21.21% | 20.76% | 25.71% | 25.36% | 29.29% | 24.91% | 23.42% | 24.38% | 2.92% |
| totLiab | 47672 | 48394 | 48183 | 48250 | 51107 | 66095 | 59446 | 52735 | 7205 |
| totLiabPct | 76.24% | 76.39% | 79.44% | 78.61% | 76.59% | 62.73% | 61.61% | 73.09% | 7.56% |
| curLiab | 15256 | 16383 | 16292 | 18117 | 20307 | 22594 | 26293 | 19320 | 4002 |
| curLiabPct | 24.40% | 25.86% | 26.86% | 29.52% | 30.43% | 21.44% | 27.25% | 26.54% | 3.05% |
| ltDebt | 14501 | 15560 | 17359 | 16217 | 17994 | 28888 | 23690 | 19173 | 5214 |
| ltDebtPct | 23.19% | 24.56% | 28.62% | 26.42% | 26.97% | 27.42% | 24.55% | 25.96% | 1.92% |
| Equity | 14854 | 14960 | 12468 | 13127 | 15622 | 39268 | 37037 | 21048 | 11753 |
| EquityPct | 23.76% | 23.61% | 20.56% | 21.39% | 23.41% | 37.27% | 38.39% | 26.91% | 7.56% |
| PB | 3.74 | 4.19 | 6.03 | 7.38 | 6.31 | 3.05 | 4.67 | 5.05 | 1.56 |
Beta
len=129
mean=11.81%
sd=20.17%
alpha=1.27%
beta=21.50%
r_sq=4.23%
lastdate=2023-03-21
firstdate=2013-02-01
logret1y=6.06%
Financial Snapshot
CompanyName=AstraZeneca plc
ID=1
Name=Ordinary Shares
Ticker=AZN
ISIN=GB0009895292
RIC=AZN.L
DisplayRIC=AZN.L
InstrumentPI=285840
QuotePI=1049533
InstrumentPermID=8590928282
QuotePermID=55836041824
Exchange=London Stock Exchange (LON)
ExchangeCode=LON
ExchangeCountry=GBR
CoStatus=Active
CoType=Equity Issue
LastModified=2023-03-01
LatestAvailableAnnual=2022-12-31
LatestAvailableInterim=2022-12-31
Employees=83500
SharesOut=1.550e+09
TotalFloat=1.495e+09
ReportingCurrency=USD
MostRecentExchange=1.0
Industry=Pharmaceuticals (NEC)
IndustryCode=5620104010
NPRICE=108
NHIG=128
NLOW=94.0
PDATE=2023-03-17
VOL10DAVG=2.32
EV=185413
MKTCAP=166664
AREV=36428
AEBITD=11360
ANIAC=2701
AEPSXCLXOR=1.73
AREVPS=23.4
ABVPS=19.6
ACSHPS=3.39
ACFSHR=4.50
ADIVSHR=2.38
AGROSMGN=80.5
AROEPCT=8.62
APR2REV=4.58
APEEXCLXOR=62.1
APRICE2BK=5.48
ConsRecom=1.93
TargetPrice=125
ProjLTGrowthRate=15.5
ProjPE=18.2
ProjSales=37549
ProjSalesQ=8939
ProjEPS=5.95
ProjEPSQ=1.32
ProjProfit=10632
ProjDPS=2.51
quoteccy=GBP
quotefx=82.60%
exchgccy=GBP
exchgfx=82.60%
tick=None
exchg=None
Valuation
ticker=AZN
exchg=LSE
RIC=AZN.L
CompanyName=AstraZeneca plc
ExchangeCode=LON
Industry=Pharmaceuticals (NEC)
IndustryCode=5620104010
sector=56 Healthcare
region=eu
ccy=USD
fx=100.00%
mktcap_usd=201779
float_usd=194595
ConsensRecom=1.93
earning_yield=2.36%
growth=10.95%
dilution=3.48%
margin=9.07%
searning_yield=1.12%
sgrowth=-1.40%
smargin=4.33%
sdilution=7.22%
projearning_yield=5.36%
earning_excl_yield=1.59%
div_ratio=1.56
bb_ratio=-1.77
sh_payout_ratio=0
PS=4.61
price=108
ratio=32.91%
sratio=8.01%
sratiopaid=6.44%
ratioConsens=1.15
turnover=38.54%
cfmargin=7.03%
rdmargin=23.10%
scfmargin=-0.49%
quoteccy=GBP
quotefx=82.60%
ratiopaid=22.72%
dt=2023-03-17
assetgrowth=7.23%
dlnfx=0